Volpara Health Technologies Limited is a breast imaging analytics and analysis company that provides products for the early detection of breast cancer. The company offers cloud-based breast imaging analytics software, patient management software, mammography reporting and patient communications software, and artificial intelligence-based software to power its products. In addition, the company provides clinical functions that determine patient positioning and provide radiation dose analysis. Volpara has a strategic relationship with RevealDx to enhance lung screening capabilities. The company was founded in 2009 and is headquartered in Wellington, New Zealand.